Company: OCEA
Filing Date: 2025-04-08
Form Type: 10-K
Source: 0001641172-25-003155
Chunk: 616

Company: Ocean Biomedical, Inc.
Filing Date: 2025-04-08
Form: 10-K
Item: Item 4
Chunk 616
---
 in fair value of Virion Contribution Liability 
     3,605  
     (777)
  
    Fair value of stock obligations 
     (47) 
     - 
  
    Other 
     -  
     (1)
  
    Total other income (expense) 
     (5,682) 
     (104,252)
  
    NET LOSS 
    $(9,480) 
    $(114,466)

    Weighted average shares outstanding, basic and diluted 
     27,502,537  
     26,292,438 
  
    Net loss per share, basic and diluted 
    $(0.34) 
    $(4.35)

See
accompanying notes to the consolidated financial statements

F-5

OCEAN
BIOMEDICAL, INC. AND SUBSIDIARIES

CONSOLIDATED
STATEMENTS OF STOCKHOLDERS’ DEFICIT

FOR THE FISCAL YEARS ENDED DECEMBER 31, 2024 AND 2023

(in
thousands)

    Shares  
    Amount  
    Capital  
    Deficit  
    Deficit 

    Common  
    Additional Paid-In  
    Accumulated  
    Total Stockholders’ 

    Shares  
    Amount  
    Capital  
    Deficit  
    Deficit 
  
    Balances at December 31, 2022 
     23,355,432  
     -  
     70,770  
     (81,589) 
     (10,819)
  
    Net loss 

     (114,466) 
     (114,466)
  
    Pre-merger liabilities assumed 
     -  
           -  
     (942) 
     -  
     (942)
  
    Effect of Business Combination, including Backstop Agreement, net of redeemed public shares 
     7,654,035  
     -  
     52,070  
     -  
     52,070 
  
    Backstop Agreement Prepayment 
     -  
     -  
     (51,606) 
     -  
     (51,606)
  
    Proceeds from Backstop Agreement 
     -  
     -  
     1,444